Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ONUREG 300 MG

AZACITIDINE : 300 MG · DIN 02510200 · BRISTOL-MYERS SQUIBB CANADA

Health Canada status: MARKETED

What is ONUREG?

ONUREG 300 MG contains AZACITIDINE : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 02510200, held by BRISTOL-MYERS SQUIBB CANADA, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Jan-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02510200
Brand nameONUREG
Generic / active ingredientAZACITIDINE : 300 MG
ManufacturerBRISTOL-MYERS SQUIBB CANADA
Strength300 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeL01BC07 AZACITIDINE
AHFS class10:00.00
BiosimilarNo
Health Canada statusMARKETED
Status date31-Jan-2025
Original market date2021-03-10 00:00:00

Is AZACITIDINE in shortage in Canada?

A Canadian shortage report is on file for this molecule: Resolved — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for ONUREG

What can be used instead?

Other Canadian products sharing ATC code L01BC07 AZACITIDINE. 7 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
AZACITIDINE FOR INJECTION100 MGPOWDER FOR SUSPENSIONFRESENIUS KABI CANADA LTDMARKETEDDIN 02505177
AZACITIDINE FOR INJECTION100 MGPOWDER FOR SUSPENSIONDR REDDY'S LABORATORIES LTDMARKETEDDIN 02462826
AZACITIDINE FOR INJECTION100 MGPOWDER FOR SUSPENSIONSANDOZ CANADA INCORPORATEDMARKETEDDIN 02529599
AZACITIDINE FOR INJECTION100 MGPOWDER FOR SUSPENSIONHIKMA CANADA LIMITEDMARKETEDDIN 02507668
ONUREG200 MGTABLETBRISTOL-MYERS SQUIBB CANADAMARKETEDDIN 02510197
VIDAZA100 MGPOWDER FOR SUSPENSIONBRISTOL-MYERS SQUIBB CANADAMARKETEDDIN 02336707
AZACITIDINE FOR INJECTION100 MGPOWDER FOR SUSPENSIONJAMP PHARMA CORPORATIONDORMANTDIN 02501791
AZACITIDINE FOR INJECTION100 MGPOWDER FOR SUSPENSIONSTERIMAX INCAPPROVEDDIN 02534029
AZACITIDINE FOR INJECTION150 MGPOWDER FOR SUSPENSIONSTERIMAX INCAPPROVEDDIN 02534037
AZACITIDINE FOR INJECTION150 MGPOWDER FOR SUSPENSIONDR REDDY'S LABORATORIES LTDAPPROVEDDIN 02558815

Who else supplies AZACITIDINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. AZACITIDINE appears in 411 registered pack listings across 10 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ONUREG

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02510200. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.